PATENT CLAIM ANALYSIS

Application Number: 15923928
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["800", "018000"]

Abstract:
In some aspects, the present invention provides chimeric transferrin receptor (TfR) polynucleotides and polypeptides. In other aspects, this invention provides chimeric TfR transgenic animal models and methods of using the animal models to identify therapeutics that can cross the blood-brain barrier.

Claim (Index 22):
The ES cell of  claim 18 , wherein the heterologous apical domain comprises an amino acid sequence having at least 80% identity to SEQ ID NO:7, SEQ ID NO:8, or SEQ ID NO:9.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 90.0
- Lexical Diversity: 1.38235
- Patent Class: 800.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15525832', '14283038', '15847448', '15203057', '15386638']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6265502397983256
- 35 USC 102 Novelty (BERT): 0.5334344088189166
- Combined Prediction Score: 0.6172386567003847
- Mean Citation Score: 334.949978
- Max Citation Score: 400.57388
- Similarity Product: 252.204151477189

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test